recurrent renal cell cancer
Showing 1 - 25 of 37
Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial
Not yet recruiting
- Clear Cell Renal Cell Carcinoma
- +2 more
- (no location specified)
May 14, 2023
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- panobinostat
- +7 more
-
Buffalo, New York
- +1 more
Aug 11, 2022
Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Buffalo (radiation, procedure, other)
Completed
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer
- stereotactic body radiation therapy
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Rochester, Madison (CCI-779,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
-
Rochester, Minnesota
- +1 more
Jan 12, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Los Angeles
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- AdGMCAIX-transduced autologous dendritic cells
- +2 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Jul 28, 2021
Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Bronx, New York (vorinostat,
Terminated
- Recurrent Renal Cell Cancer
- +2 more
-
Bronx, New York
- +1 more
Feb 1, 2021
Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in
Completed
- Acute Undifferentiated Leukemia
- +63 more
- total-body irradiation
- +7 more
-
Seattle, Washington
- +1 more
Jan 17, 2020
Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (drug, radiation, procedure, biological, other)
Completed
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer
- fludarabine phosphate
- +7 more
-
Tucson, Arizona
- +5 more
Jul 23, 2019
Fatigue, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Cleveland (procedure, other, drug)
Terminated
- Fatigue
- +2 more
- transcranial magnetic stimulation
- +3 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Nov 14, 2018
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Houston (procedure, drug,
Terminated
- Clear Cell Renal Cell Carcinoma
- +2 more
- therapeutic conventional surgery
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 22, 2018
Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected
Completed
- Recurrent Melanoma
- +11 more
- siRNA-transfected peripheral blood mononuclear cells APN401
- laboratory biomarker analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 2, 2018
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Cleveland (tandutinib,
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- tandutinib
- laboratory biomarker analysis
-
Cleveland, OhioCase Western Reserve University
Oct 19, 2017
Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer Trial in Duarte (fluorescence imaging,
Completed
- Recurrent Renal Cell Cancer
- +2 more
- fluorescence imaging
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 11, 2017
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (drug, other,
Terminated
- Clear Cell Renal Cell Carcinoma
- +2 more
- pazopanib hydrochloride
- +3 more
-
Chicago, Illinois
- +3 more
May 8, 2017
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Stanford (radiation, drug,
Terminated
- Clear Cell Renal Cell Carcinoma
- +2 more
- stereotactic body radiation therapy
- +3 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Mar 13, 2017
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Baltimore, Salisbury, Madison
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
-
Baltimore, Maryland
- +2 more
Dec 10, 2015
Recurrent Renal Cell Cancer Trial in Los Angeles (robot-assisted laparoscopic surgery)
Terminated
- Recurrent Renal Cell Cancer
- robot-assisted laparoscopic surgery
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Mar 25, 2015
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Chicago (cediranib maleate,
Terminated
- Clear Cell Renal Cell Carcinoma
- +2 more
- cediranib maleate
- laboratory biomarker analysis
-
Chicago, IllinoisUniversity of Chicago
May 5, 2014
Recurrent Renal Cell Cancer, Renal Cell Carcinoma, Stage III Renal Cell Cancer Trial in United States (etaracizumab,
Terminated
- Recurrent Renal Cell Cancer
- +3 more
- etaracizumab
- bevacizumab
-
Marysville, California
- +4 more
Apr 28, 2014
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer Trial in Baltimore, Madison (drug,
Completed
- Clear Cell Renal Cell Carcinoma
- +6 more
- sunitinib malate
- +6 more
-
Baltimore, Maryland
- +1 more
Apr 1, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014
Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Duarte (recombinant interferon alfa, oblimersen sodium,
Completed
- Recurrent Renal Cell Cancer
- Stage IV Renal Cell Cancer
- recombinant interferon alfa
- +2 more
-
Duarte, CaliforniaCity of Hope
Aug 23, 2013
Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer Trial in United States (BAY 56-3722, enzyme inhibitor therapy)
Withdrawn
- Stage IV Renal Cell Cancer
- Recurrent Renal Cell Cancer
- BAY 56-3722
- enzyme inhibitor therapy
-
Little Rock, Arkansas
- +25 more
Jul 9, 2013
Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Cancer Trial in Durham (drug, biological,
Terminated
- Clear Cell Renal Cell Carcinoma
- +4 more
- sorafenib tosylate
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jul 1, 2013
Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer Trial run by the NCI (bevacizumab, thalidomide)
Completed
- Stage IV Renal Cell Cancer
- Recurrent Renal Cell Cancer
-
Bethesda, MarylandSurgery Branch
Jun 19, 2013